The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS)
ConclusionOur real-world findings on LNG-IUS-19.5 mg use in German KYSS participants reflected its suitability for a broad population, including young and nulliparous women.Clinical trial registrationNCT03182140 (date of registration: June 2017).
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Amenorrhea | Bleeding | Clinical Trials | Germany Health | Mirena | OBGYN | Pain | Study | Women